BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34461287)

  • 1. Glucose variability and low bone turnover in people with type 2 diabetes.
    Starup-Linde J; Lykkeboe S; Handberg A; Vestergaard P; Høyem P; Fleischer J; Hansen TK; Poulsen PL; Laugesen E
    Bone; 2021 Dec; 153():116159. PubMed ID: 34461287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in biochemical bone markers by diabetes type and the impact of glucose.
    Starup-Linde J; Lykkeboe S; Gregersen S; Hauge EM; Langdahl BL; Handberg A; Vestergaard P
    Bone; 2016 Feb; 83():149-155. PubMed ID: 26555635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes.
    Starup-Linde JK; Viggers R; Langdahl B; Gregersen S; Lykkeboe S; Handberg A; Vestergaard P
    Front Endocrinol (Lausanne); 2021; 12():649718. PubMed ID: 33790870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
    Westberg-Rasmussen S; Starup-Linde J; Hermansen K; Holst JJ; Hartmann B; Vestergaard P; Gregersen S
    Bone; 2017 Apr; 97():261-266. PubMed ID: 28126633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus.
    Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Jørgensen NR; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Krarup T; Madsbad S; Mathiesen ER; Perrild H; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
    Calcif Tissue Int; 2020 Aug; 107(2):160-169. PubMed ID: 32468187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSH may mediate the association between HbA1c and bone turnover markers in postmenopausal women with type 2 diabetes.
    Zha KX; An ZM; Ge SH; Cai J; Zhou Y; Ying R; Zhou J; Gu T; Guo H; Zhao Y; Wang NJ; Lu YL
    J Bone Miner Metab; 2022 May; 40(3):468-477. PubMed ID: 35059887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased markers of bone turnover in children and adolescents with type 1 diabetes.
    Madsen JOB; Herskin CW; Zerahn B; Jørgensen NR; Olsen BS; Pociot F; Johannesen J
    Pediatr Diabetes; 2020 May; 21(3):505-514. PubMed ID: 31970841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive association of glucagon with bone turnover markers in type 2 diabetes: A cross-sectional study.
    Guo H; Sui C; Ge S; Cai J; Lin D; Guo Y; Wang N; Zhou Y; Ying R; Zha K; Gu T; Zhao Y; Lu Y; An Z
    Diabetes Metab Res Rev; 2022 Sep; 38(6):e3550. PubMed ID: 35621313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults.
    Napoli N; Strollo R; Defeudis G; Leto G; Moretti C; Zampetti S; D'Onofrio L; Campagna G; Palermo A; Greto V; Manfrini S; Hawa MI; Leslie RD; Pozzilli P; Buzzetti R;
    J Clin Endocrinol Metab; 2018 May; 103(5):1921-1928. PubMed ID: 29506222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum levels of bone turnover markers are associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes mellitus.
    An Y; Liu S; Wang W; Dong H; Zhao W; Ke J; Zhao D
    J Diabetes; 2021 Feb; 13(2):111-123. PubMed ID: 32671958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
    Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
    Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between Mean Amplitude of Glycemic Excursion and Bone Turnover Markers in Patients with Type 2 Diabetes: A Cross-Sectional Study.
    Yang J; Zheng C; Wang Y; Yang L; Liu L
    Diabetes Metab Syndr Obes; 2023; 16():397-407. PubMed ID: 36798908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes.
    Napoli N; Conte C; Eastell R; Ewing SK; Bauer DC; Strotmeyer ES; Black DM; Samelson EJ; Vittinghoff E; Schwartz AV
    J Bone Miner Res; 2020 Dec; 35(12):2363-2371. PubMed ID: 32717111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity.
    Fuglsang-Nielsen R; Rakvaag E; Vestergaard P; Hartmann B; Holst JJ; Hermansen K; Gregersen S; Starup-Linde J
    Bone; 2020 Apr; 133():115230. PubMed ID: 31954199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover markers in children and adolescents with type 1 diabetes-A systematic review.
    Madsen JOB; Jørgensen NR; Pociot F; Johannesen J
    Pediatr Diabetes; 2019 Aug; 20(5):510-522. PubMed ID: 30941847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low bone turnover in premenopausal women with type 2 diabetes mellitus as an early process of diabetes-associated bone alterations: a cross-sectional study.
    Purnamasari D; Puspitasari MD; Setiyohadi B; Nugroho P; Isbagio H
    BMC Endocr Disord; 2017 Nov; 17(1):72. PubMed ID: 29187183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose.
    Maagensen H; Junker AE; Jørgensen NR; Gluud LL; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2018 May; 103(5):2042-2049. PubMed ID: 29506157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose.
    Mathiesen IH; Hitz MF; Katzenstein TL; Oturai P; Skov M; Jørgensen NR; Jensen PO; Mikkelsen CR; Krogh-Madsen R; Pressler T; Faurholt-Jepsen D
    J Cyst Fibros; 2019 May; 18(3):436-441. PubMed ID: 30928333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with type 2 diabetes mellitus have lower cortical porosity of the proximal femoral shaft using low-resolution CT than nondiabetic women, and increasing glucose is associated with reduced cortical porosity.
    Osima M; Kral R; Borgen TT; Høgestøl IK; Joakimsen RM; Eriksen EF; Bjørnerem Å
    Bone; 2017 Apr; 97():252-260. PubMed ID: 28161589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.